TransMedics Group, Inc. TMDX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 59.9%+0.6pp | 59.4%-4.4pp | 63.8%-6.1pp | 69.8%-0.1pp | |
| Operating margin | 17.9%+9.4pp | 8.5%+21.5pp | -13%+20.7pp | -33.6%+96.7pp | |
| Net margin | 31.4%+23.4pp | 8%— | —— | -38.8%+107pp | |
| EBITDA margin | 22.4%+9.5pp | 13%+22.5pp | -9.6%+20.3pp | -29.9%+94.4pp | |
| Free cash flow margin | 22.1%— | —— | -68.2%-6.5pp | -61.8%+45.2pp | |
| Returns | |||||
| Return on equity | 54.2%+34.8pp | 19.4%— | —— | -28.4%+23.1pp | |
| Return on assets | 20.3%+15.6pp | 4.7%— | —— | -17.6%+13.2pp | |
| Efficiency | |||||
| Asset turnover | 0.6×+0.1× | 0.6×+0.1× | 0.5×0.0× | 0.5×+0.2× | |
| Inventory turnover | 5.1×+1.1× | 4×+1.3× | 2.7×+1.1× | 1.6×+0.9× | |
| Liquidity | |||||
| Current ratio | 7.1×-1.2× | 8.3×-1.0× | 9.3×-1.4× | 10.7×+5.6× | |
| Quick ratio | 6.6×-0.9× | 7.5×-1.0× | 8.5×-1.3× | 9.8×+5.3× | |
| Cash ratio | 5.5×-0.2× | 5.6×-1.6× | 7.2×-1.3× | 8.5×+7.4× | |
| Leverage | |||||
| Debt-to-equity | 0.1×-0.2× | 0.3×-0.2× | 0.5×+0.1× | 0.4×-0.3× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.2×-0.1× | |
| Net debt / EBITDA | -3.1×+1.6× | -4.7×— | —— | —— | |
| Interest coverage | 7.9×+5.3× | 2.6×+5.5× | -2.9×+5.5× | -8.4×+1.7× | |
| Per Share | |||||
| Book value per share | $11.67+79.8% | $6.49+53.8% | $4.22-33.4% | $6.34+158% | |
| Valuation | |||||
| Market capitalization | $4.16B+98.7% | $2.09B-18.8% | $2.58B+30.8% | $1.97B+270% | |
| Enterprise value | $3.74B+105% | $1.82B-18.9% | $2.25B+22.5% | $1.84B+234% | |
| Price / earnings | 21.8×-37.2× | 59×— | —— | —— | |
| Price / sales | 6.9×+2.1× | 4.7×-5.9× | 10.7×-10.4× | 21.1×+3.5× | |
| Price / book | 8.8×-0.4× | 9.2×-9.6× | 18.8×+8.3× | 10.5×+2.7× | |
| EV / EBITDA | 27.5×-4.3× | 31.9×— | —— | —— | |
| EV / sales | 6.2×+2.0× | 4.1×-5.2× | 9.3×-10.3× | 19.7×+1.5× | |
| Free cash flow yield | 3.2%— | —— | -6.4%-3.5pp | -2.9%+3.2pp | |
| Earnings yield | 4.6%+2.9pp | 1.7%— | —— | -1.8%+6.5pp | |
| PEG ratio | 0.1×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TransMedics Group, Inc.'s profit margins?
- TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
- Where do TransMedics Group, Inc.'s ratios come from?
- Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
